These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 1463972

  • 1. Faecal steroids and colorectal cancer: steroid profiles in subjects with adenomatous polyps of the large bowel.
    Owen RW, Day DW, Thompson MH.
    Eur J Cancer Prev; 1992 Feb; 1(2):105-12. PubMed ID: 1463972
    [Abstract] [Full Text] [Related]

  • 2. Faecal bile acids and colorectal cell proliferation. The ECP Colon Cancer Working Group.
    Biasco G, Paganelli GM, Owen RW, Hill MJ.
    Eur J Cancer Prev; 1991 Oct; 1 Suppl 2():63-8. PubMed ID: 1842735
    [No Abstract] [Full Text] [Related]

  • 3. Fecal bile acid profiles of Japanese patients with adenomatous polyps of the large bowel: special reference to distribution, multiplicity, size and degree of dysplasia of the polyps.
    Tanida N, Hikasa Y, Shimoyama T, Setchell KD.
    Jpn J Cancer Res; 1985 Feb; 76(2):104-12. PubMed ID: 3920099
    [Abstract] [Full Text] [Related]

  • 4. Fecal steroids and colorectal cancer.
    Owen RW, Dodo M, Thompson MH, Hill MJ.
    Nutr Cancer; 1987 Feb; 9(2-3):73-80. PubMed ID: 3562296
    [Abstract] [Full Text] [Related]

  • 5. Clinical significance of small colorectal polyps.
    Church JM.
    Dis Colon Rectum; 2004 Apr; 47(4):481-5. PubMed ID: 14994108
    [Abstract] [Full Text] [Related]

  • 6. Faecal steroids and colorectal cancer: the effect of lactulose on faecal bacterial metabolism in a continuous culture model of the large intestine.
    Fadden K, Owen RW.
    Eur J Cancer Prev; 1992 Feb; 1(2):113-27. PubMed ID: 1463973
    [Abstract] [Full Text] [Related]

  • 7. Large bowel adenomas: markers of risk and endpoints.
    Baron JA.
    J Cell Biochem Suppl; 1996 Feb; 25():142-8. PubMed ID: 9027611
    [Abstract] [Full Text] [Related]

  • 8. Fecal neutral steroids in normal conditions and in patients with polyps or cancer of the large bowel.
    Ponz de Leon M, Roncucci L, di Donato P, Sacchetti C, Pezcoller C, Annoni C, Bertani C, Rebecchi P, Balli F, Galli D.
    Cancer Res; 1987 Jan 01; 47(1):305-10. PubMed ID: 3791216
    [Abstract] [Full Text] [Related]

  • 9. Fecal steroids in polyposis coli and ileorectostomy patients.
    Watne AL, Core SK.
    J Surg Res; 1975 Sep 01; 19(3):157-61. PubMed ID: 1100901
    [No Abstract] [Full Text] [Related]

  • 10. A bile acid-induced apoptosis assay for colon cancer risk and associated quality control studies.
    Bernstein C, Bernstein H, Garewal H, Dinning P, Jabi R, Sampliner RE, McCuskey MK, Panda M, Roe DJ, L'Heureux L, Payne C.
    Cancer Res; 1999 May 15; 59(10):2353-7. PubMed ID: 10344743
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Predictive value of morphologic characteristics in rectosigmoid adenomatous polyps for the probability of synchronous polyps or cancer in the proximal colon.
    Erdem L, Akbayir N, Yildirim S, Köksal HM, Yenice N, Gültekin OS, Sakiz D, Peker O.
    Turk J Gastroenterol; 2005 Dec 15; 16(4):207-11. PubMed ID: 16547849
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Faecal neutral sterols and bile acids in patients with adenomas and large bowel cancer: an ECP case-control study. European cancer prevention.
    Roy P, Owen RW, Faivre J, Scheppach W, Saldanha MH, Beckly DE, Boutron MC.
    Eur J Cancer Prev; 1999 Oct 15; 8(5):409-15. PubMed ID: 10548396
    [Abstract] [Full Text] [Related]

  • 16. Asymptomatic colorectal neoplasia and fecal characteristics: a case-control study of subjects participating in the nottingham fecal occult blood screening trial.
    Little J, Owen RW, Fernandez F, Hawtin PG, Hill MJ, Logan RF, Thompson MH, Hardcastle JD.
    Dis Colon Rectum; 2002 Sep 15; 45(9):1233-41. PubMed ID: 12352242
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Smoking exposure as a risk factor for prevalent and recurrent colorectal adenomas.
    Reid ME, Marshall JR, Roe D, Lebowitz M, Alberts D, Battacharyya AK, Martinez ME.
    Cancer Epidemiol Biomarkers Prev; 2003 Oct 15; 12(10):1006-11. PubMed ID: 14578135
    [Abstract] [Full Text] [Related]

  • 20. [Serum concentration of insulin, C-peptide and insulin-like growth factor I in patients with colon adenomas and colorectal cancer].
    Kaczka A, Kumor A, Pietruczuk M, Małecka-Panas E.
    Pol Merkur Lekarski; 2007 May 15; 22(131):373-5. PubMed ID: 17679371
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.